Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota
Hao Hua, Chaoli Huang, Hanyu Liu, et al.
Neuropharmacology (2022) Vol. 220, pp. 109272-109272
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Arketamine for cognitive impairment in psychiatric disorders
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1513-1525
Open Access | Times Cited: 32
Neuroinflammation through the vagus nerve-dependent gut–microbiota–brain axis in treatment-resistant depression
Kenji Hashimoto
Progress in brain research (2023), pp. 61-77
Closed Access | Times Cited: 31
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
Depression-like phenotypes in mice following common bile duct ligation: Insights into the gut–liver–brain axis via the vagus nerve
Yong Yang, Akifumi Eguchi, Chisato Mori, et al.
Neurobiology of Disease (2024) Vol. 192, pp. 106433-106433
Open Access | Times Cited: 10
Repeated ( S )-ketamine administration ameliorates the spatial working memory impairment in mice with chronic pain: role of the gut microbiota–brain axis
Yubin Jiang, Xingming Wang, Jiawei Chen, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Depression-like phenotypes in mice with hepatic ischemia/reperfusion injury: A role of gut–microbiota–liver–brain axis via vagus nerve
Yong Yang, Akifumi Eguchi, Xiayun Wan, et al.
Journal of Affective Disorders (2023) Vol. 345, pp. 157-167
Closed Access | Times Cited: 15
Beneficial effects of arketamine on the reduced bone mineral density in susceptible mice after chronic social defeat stress: Role of the gut–microbiota–bone–brain axis
Xiayun Wan, Akifumi Eguchi, Lijia Chang, et al.
Neuropharmacology (2023) Vol. 228, pp. 109466-109466
Open Access | Times Cited: 14
Interactions Between Antidepressants and Intestinal Microbiota
Feiyu Xu, Qinglian Xie, Weihong Kuang, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 2, pp. 359-371
Closed Access | Times Cited: 13
A role of gut–brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress
Li Ma, Akifumi Eguchi, Guilin Liu, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 238, pp. 173736-173736
Closed Access | Times Cited: 5
The Microbial and Metabolic Link Between Gut and Brain
Rand Salamalek, Yasmin Shareef, Farah Abdulridha, et al.
(2025), pp. 441-469
Closed Access
Repeated administration of esketamine ameliorates mechanical allodynia in mice with chemotherapy-induced peripheral neuropathy: A role of gut microbiota and metabolites
Wei-Wei Luan, Hanwen Gu, Di Qiu, et al.
Neurochemistry International (2025) Vol. 185, pp. 105961-105961
Closed Access
S-ketamine alleviates morphine-induced hyperalgesia via decreasing the gut Enterobacteriaceae levels: Comparison with R-ketamine
Hanyu Liu, Siqi Yang, Qi Zhang, et al.
Neuroscience (2025)
Closed Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Antidepressants in the post-ketamine Era: Pharmacological approaches targeting the glutamatergic system
Shigeyuki Chaki, Mai Watanabe
Neuropharmacology (2022) Vol. 223, pp. 109348-109348
Closed Access | Times Cited: 16
Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review
Lisa Brown, William V. Bobo, Cory A. Gall, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1086-1086
Open Access | Times Cited: 9
Two Omics Methods Expose Anti‐Depression Mechanism of Raw and Vinegar‐Baked Bupleurum Scorzonerifolium Willd
Zhongyuan Qu, Yan Zheng, Shuang Wu, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 2
Impact of antidepressants on the composition of the gut microbiome: A systematic review and meta-analysis of in vivo studies
Jann Aldrin Gamboa, Gia Han Le, Sabrina Wong, et al.
Journal of Affective Disorders (2024)
Closed Access | Times Cited: 2
Ketamine, benzoate, and sarcosine for treating depression
Yu‐Jung Cheng, Chieh‐Hsin Lin, Hsien‐Yuan Lane
Neuropharmacology (2022) Vol. 223, pp. 109351-109351
Closed Access | Times Cited: 11
Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options
Wenjie Han, Na Wang, Mengzhen Han, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 10
Ketamine and its metabolites: Potential as novel treatments for depression
Kenji Hashimoto, Shigeyuki Chaki
Neuropharmacology (2023) Vol. 230, pp. 109492-109492
Closed Access | Times Cited: 4
Therapeutic Potential of Ketamine in Management of Epilepsy: Clinical Implications and Mechanistic Insights
Yunfei Tan, Kenji Hashimoto
Asian Journal of Psychiatry (2024) Vol. 101, pp. 104246-104246
Open Access | Times Cited: 1
Structural characteristics and potential antidepressant mechanism of a water-insoluble β-1,3-glucan from an edible fungus Wolfiporia cocos
Xinyao Luo, Meng Yu, Huijun Li, et al.
Carbohydrate Polymers (2024) Vol. 348, pp. 122779-122779
Closed Access | Times Cited: 1
Ginsenoside Rg1: A Neuroprotective Natural Dammarane‐Type Triterpenoid Saponin With Anti‐Depressive Properties
Dong Han, Zheng Zhao, Tianyang Mao, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 12
Closed Access | Times Cited: 1
Association between gut microbiota and post-stroke depression in Chinese population: A meta-analysis
Fang Luo, Chengbing Fang
Heliyon (2022) Vol. 8, Iss. 12, pp. e12605-e12605
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top